The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 340:1754-1756 June 3, 1999 Number 22
NextNext

The New Immunology — The End of Immunosuppressive Drug Therapy?

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Guinan, E. C.
-Related Article
 by Atzpodien, J.
-PubMed Citation
In 1970, almost a decade before molecular biology began to make its mark on immunology, Bretscher and Cohn1 advanced a novel theory to explain how the immune system responds to foreign proteins. Stripped to its core and recast in modern terms, their model holds that the initiation of an immune response requires two signals: signal 1 and signal 2. The effect of these signals is to activate lymphocytes of the helper type, which, when activated, can induce B cells to produce antibodies or prepare cytotoxic T cells for cell killing. The necessary activating signals arise when the helper T cell . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.